Product image of Milgamma (Benfotiamine, Pyridoxine Hydrochloride) supplied by GNH India

Milgamma

Active Ingredient:
Benfotiamine, Pyridoxine Hydrochloride
Origin:
EU

Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine, the active ingredient in Milgamma, is a Vitamin B1 analogue presented as a nutritional supplement for oral use. It is combined with pyridoxine hydrochloride, a Vitamin B6 source, to support metabolic processes and nerve health in adults.
GNH India supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Milgamma, containing benfotiamine and pyridoxine, is used to support conditions related to nerve function and vitamin B deficiencies.

  • Diabetic peripheral neuropathy: helps maintain nerve health and may alleviate sensory symptoms.
  • Alcohol‑induced neuropathy: provides vitamin B1 and B6 support to reduce nerve damage.
  • Vitamin B6 deficiency: restores normal pyridoxine levels for enzymatic reactions.
  • General nutritional support: contributes to overall metabolic function in individuals with increased vitamin needs.

How It Works

  • Benfotiamine, a lipid‑soluble thiamine derivative, is converted to thiamine diphosphate, enhancing glucose metabolism and reducing formation of advanced glycation end‑products. Pyridoxine hydrochloride is converted to pyridoxal‑5‑phosphate, a co‑factor for amino‑acid transamination, neurotransmitter synthesis, and hemoglobin formation, thereby supporting neuronal and metabolic processes.

Side Effects

Milgamma is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects

  • Nausea: mild stomach upset after ingestion.
  • Abdominal discomfort: occasional cramps or bloating.
  • Headache: transient mild headache.
  • Skin rash: mild erythema or itching.
  • Dizziness: brief light‑headedness.

Serious or Rare Side Effects

  • Anaphylactic reaction: severe allergic response requiring immediate medical attention.
  • Stevens‑Johnson syndrome: rare severe skin eruption.
  • Hepatic enzyme elevation: abnormal liver function tests.
  • Hematologic abnormalities: rare blood dyscrasias.
  • Severe hypersensitivity: swelling of face, lips, or throat.

Precautions & Warnings

When considering Milgamma, take the following precautions.

  • Assess vitamin status: evaluate baseline B1/B6 levels before supplementation.
  • Monitor for allergies: discontinue if signs of hypersensitivity appear.
  • Renal or hepatic impairment: use with caution and under medical supervision.
  • Interaction with levodopa: pyridoxine may reduce levodopa efficacy; consult a physician.
  • Pregnancy and breastfeeding: discuss use with a healthcare professional before starting.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Milgamma may interact with certain medications; awareness of these interactions helps ensure safety.

Major Interactions (Avoid)

  • Levodopa: pyridoxine can diminish levodopa absorption and effectiveness.
  • High‑dose chemotherapy agents: excessive vitamin B6 may interfere with treatment efficacy.

Moderate Interactions (Monitor Closely)

  • Antidiabetic drugs: benfotiamine may influence glucose control, requiring monitoring.
  • Diuretics: increased urinary excretion may affect vitamin levels.
  • Anticonvulsants: pyridoxine can alter metabolism of some seizure medications.

Frequently Asked Questions

Milgamma is a nutritional supplement that combines benfotiamine (a Vitamin B1 analogue) and pyridoxine hydrochloride (Vitamin B6). It is commonly used to support nerve health in conditions such as diabetic or alcohol‑related neuropathy and to address vitamin B6 deficiency or general metabolic needs.

Benfotiamine is a lipid‑soluble form of thiamine that readily enters cells and is converted to thiamine diphosphate. This co‑factor participates in glucose metabolism, helps reduce the formation of harmful advanced glycation end‑products, and supports the function of peripheral nerves.

The appropriate dose of Milgamma is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, and overall health. Patients should follow the specific instructions provided by their doctor or pharmacist.

Safety data for Milgamma in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using the product.

To order Milgamma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Milgamma combines benfotiamine, a highly bioavailable thiamine derivative, with pyridoxine hydrochloride, offering both Vitamin B1 and B6 in one formulation. Compared with standard thiamine or pyridoxine tablets, benfotiamine provides better cellular uptake, which may enhance metabolic and neuroprotective effects.

Milgamma should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Milgamma is taken orally, usually with water. The exact timing (e.g., with meals or on an empty stomach) should follow the prescribing clinician’s guidance to optimize absorption and minimize gastrointestinal discomfort.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, significant liver enzyme elevations, and hematologic abnormalities. Any signs of these conditions require immediate medical attention.

Individuals with known hypersensitivity to benfotiamine, pyridoxine, or any excipients in the formulation should avoid Milgamma. Patients on levodopa therapy should consult a physician before use, and those with severe renal or hepatic impairment should be evaluated by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Benfotiamine, Pyridoxine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT